Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




New Electronic Pipette Designed for Accuracy and Comfort

By LabMedica International staff writers
Posted on 30 Jul 2013
A new line of electronic pipettes ensures error-free and comfortable pipetting even when performing repetitive routine procedures.

The INTEGRA Biosciences AG (Zizers, Switzerland) PIPETBOY pro weighs only 190 grams and was ergonomically designed for a comfortable fit in order to reduce the labor involved in prolonged pipetting tasks.

The PIPETBOY pro is a precision instrument that enables accurate liquid transfer at variable speeds that is controlled by finger pressure on the pipette's trigger. More...
The user can dispense liquids drop-by-drop with slight pressure on the trigger, or, by fully pressing on the trigger, engage the powerful pump motor to quickly empty the pipette. Accurate and reliable results can be achieved quickly even by occasional users at pipetting speeds of up to 12 milliliters per second.

INTEGRA, a leading supplier of high-quality laboratory tools for liquid handling, media preparation, sterilization, and cell cultivation, has added a clever innovation to the PIPETBOY pro. The pipette is outfitted with an integral white LED light that provides strong illumination of the area around the pipette, ensuring accurate pipetting and preventing eyestrain.

Related Links:

INTEGRA Biosciences AG



Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Turbidimetric Control
D-Dimer Turbidimetric Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.